Levetiracetam Injection, Solution, Concentrate
Product Images NDC 85957-037

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 85957-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aryeh Pharma Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Levetiracetam Fig 1)

This is a chart showing the percentage of patients in each group. The study includes a placebo group (N=5), a group taking Levetiracetam 1000 mg/day (N=97), and a group taking Levetiracetam 3000 mg/day (N=101). The text mentions that the data for Levetiracetam 1000 mg/day was statistically significant when compared to the placebo group.*

FDA Label Image

"image Description" (Levetiracetam Fig 2)

This text provides a comparison of patient percentages for a study with a placebo group and two different doses of levetiracetam (1000 mg/day and 2000 mg/day). The data indicates statistically significant results were found in comparison to the placebo group.*

FDA Label Image

"image Description" (Levetiracetam Fig 3)

This text provides data on the percentage of patients experiencing a certain outcome for a placebo group (N=104) and a group taking Levetiracetam 3000 mg/day (N=180). It states that the results with Levetiracetam were statistically significant compared to the placebo group.*

FDA Label Image

"image Description" (Levetiracetam Fig 4)

This is a statistical comparison of the effectiveness of two treatments: placebo (97 patients) and levetiracetam (101 patients). The table shows the percentage of patients for each treatment group. The statement "* Statistically significant versus placebo" indicates that there is a significant difference between the two treatments in terms of their effectiveness.*

FDA Label Image

"image Description" (Levetiracetam Fig 5)

This is a data table showing the percentage of patients in two groups (Placebo and Levetiracetam) in a study or clinical trial. The table suggests that the Levetiracetam group had a statistically significant effect compared to the Placebo group. The study had 51 patients in the Placebo group and 58 patients in the Levetiracetam group.*

FDA Label Image

"image Description" (Levetiracetam Fig 6)

This text provides statistical information about the effectiveness of Levetiracetam compared to a placebo in a medical study. The data includes the percentage of patients in each group and highlights that the difference in effectiveness between the two treatments is statistically significant.*

FDA Label Image

"image Description" (Levetiracetam Injection 1)

FDA Label Image

"image Description" (Levetiracetam Injection 2)

This text provides formulas for calculating estimated creatinine clearance based on age, weight, and serum creatinine levels. The formula varies slightly for female patients, who should multiply the result by 0.85. This information can be used in medical settings to assess kidney function.*

FDA Label Image

"image Description" (Levetiracetam Injection 3)

FDA Label Image

"image Description" (Levetiracetam Injection 4)

FDA Label Image

"image Description" (Levetiracetam Label)

This text provides details about a medication called Levetiracetam, which is in injectable form with a concentration of 500 mg/5 mL (100 mg/mL). It is intended for intravenous use only and must be diluted before administration. The medication comes in single-dose vials and any unused portion should be discarded. The storage instructions suggest keeping it at 20%-25°C (68°-77°F). The manufacturer is BDR Pharmaceuticals Intl Pvt. Ltd. in India, and it is marketed by Aryeh Pharma Corp in the United States. Additional dosage and administration details can be found in the package insert.*

FDA Label Image

"image Description" (Levetiracetam Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.